Clinical trial
Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute…
NCT00004496 · University of Texas, Other · Completed
Key facts
| NCT number | NCT00004496 |
|---|---|
| Title | Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure |
| Lead sponsor | University of Texas, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acute Renal Failure |
| Intervention type | Drug |
| Interventions | alpha-melanocyte stimulating hormone |
| Enrollment | 45 |
| Start date | Feb 1, 1999 |
| Completion | Sep 1, 2003 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: